Examples of TAAs targeted in pediatric glioma vaccines include the cytomegalovirus (CMV) pp65 antigen and glioma-associated antigens (GAAs) such as EphA2, IL13RA2, and Survivin. This evidence concerns the gene BIRC5 and glioma.